Literature DB >> 22205026

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.

Nirmal K Banda1, Stephanie Hyatt, Alexandra H Antonioli, Jason T White, Magdalena Glogowska, Kazue Takahashi, Tod J Merkel, Gregory L Stahl, Stacey Mueller-Ortiz, Rick Wetsel, William P Arend, V Michael Holers.   

Abstract

The complement system, especially the alternative pathway, plays essential roles in the induction of injury in collagen Ab-induced arthritis (CAIA) in mice. The goal of the current study was to directly compare the roles of receptors for C3a and C5a, as well as the membrane attack complex, as effector mechanisms in the pathogenesis of CAIA. Clinical disease activity in C3aR(-/-), C5aR(-/-), and C6-deficient (C6-def) mice was decreased by 52, 94, and 65%, respectively, as compared with wild-type mice. Decreases in histopathologic injury as well as in IgG and C3 deposition paralleled the clinical disease activity. A decrease in the percentage of synovial neutrophils was observed in C3aR(-/-), C5aR(-/-), and C6-def mice, and a decrease in macrophages was observed in C3aR(-/-) and C5aR(-/-), but not in C6-def, mice. Synovial mRNA obtained by laser capture microdissection exhibited a decrease in TNF-α in C5aR(-/-) mice and in IL-1β in both C5aR(-/-) and C6-def mice, whereas C3aR(-/-) mice demonstrated no change in either cytokine. Our findings show that absent C3aR-, C5aR-, or membrane attack complex-initiated effector mechanisms each decrease susceptibility to CAIA, with clinical effects most pronounced in C5aR-deficient mice. Although the absence of C3aR, C5aR, or C6 led to differential deficiencies in effector mechanisms, decreased proximal joint IgG and C3 deposition was common to all three genotypes in comparison with wild-type mice. These data suggest the existence of positive-feedback amplification pathways downstream of all three effectors that promote additional IgG deposition and C3 activation in the joint.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205026      PMCID: PMC3262949          DOI: 10.4049/jimmunol.1102310

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2.

Authors:  Norma P Gerard; Bao Lu; Pixu Liu; Stewart Craig; Yuko Fujiwara; Shoji Okinaga; Craig Gerard
Journal:  J Biol Chem       Date:  2005-10-04       Impact factor: 5.157

2.  Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization.

Authors:  Puran S Bora; Jeong-Hyeon Sohn; Jose M C Cruz; Purushottam Jha; Hiroki Nishihori; Yali Wang; Sankaranarayanan Kaliappan; Henry J Kaplan; Nalini S Bora
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 3.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.

Authors:  Julia Skokowa; Syed R Ali; Olga Felda; Varsha Kumar; Stephanie Konrad; Nelli Shushakova; Reinhold E Schmidt; Roland P Piekorz; Bernd Nürnberg; Karsten Spicher; Lutz Birnbaumer; Jörg Zwirner; Jill W C Claassens; Josef S Verbeek; Nico van Rooijen; Jörg Köhl; J Engelbert Gessner
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

Review 5.  Role of C5a in inflammatory responses.

Authors:  Ren-Feng Guo; Peter A Ward
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 6.  Rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

7.  Molecular basis for complement component 6 (C6) deficiency in rats and mice.

Authors:  Deepak Bhole; Gregory L Stahl
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

8.  Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.

Authors:  E Berla Thangam; Rampura T Venkatesha; Asifa K Zaidi; Kelly L Jordan-Sciutto; Dmitry A Goncharov; Vera P Krymskaya; Yassine Amrani; Reynold A Panettieri; Hydar Ali
Journal:  FASEB J       Date:  2005-03-09       Impact factor: 5.191

9.  Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.

Authors:  Nicole L Tramontini; Paul J Kuipers; Colleen M Huber; Kerri Murphy; Keith B Naylor; Autumn J Broady; Kenneth S Kilgore
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

10.  Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis.

Authors:  Ethan P Grant; Dominic Picarella; Timothy Burwell; Tracy Delaney; Alisa Croci; Nicole Avitahl; Alison A Humbles; Jose-Carlos Gutierrez-Ramos; Michael Briskin; Craig Gerard; Anthony J Coyle
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  54 in total

1.  The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Authors:  Masha Fridkis-Hareli; Michael Storek; Eran Or; Richard Altman; Suresh Katti; Fang Sun; Tao Peng; Jeff Hunter; Krista Johnson; Yi Wang; Ante S Lundberg; Gaurav Mehta; Nirmal K Banda; V Michael Holers
Journal:  Mol Immunol       Date:  2018-12-01       Impact factor: 4.407

Review 2.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

4.  Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Authors:  William P Arend; Gaurav Mehta; Alexandra H Antonioli; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

5.  C5a receptor (CD88) blockade protects against MPO-ANCA GN.

Authors:  Hong Xiao; Daniel J Dairaghi; Jay P Powers; Linda S Ertl; Trageen Baumgart; Yu Wang; Lisa C Seitz; Mark E T Penfold; Lin Gan; Peiqi Hu; Bao Lu; Norma P Gerard; Craig Gerard; Thomas J Schall; Juan C Jaen; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

Review 6.  Applications of RNA interference in the treatment of arthritis.

Authors:  Muhammad Farooq Rai; Hua Pan; Huimin Yan; Linda J Sandell; Christine T N Pham; Samuel A Wickline
Journal:  Transl Res       Date:  2019-07-10       Impact factor: 7.012

Review 7.  Targeting mechanisms at sites of complement activation for imaging and therapy.

Authors:  V Michael Holers
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

8.  VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.

Authors:  Sabrina Ceeraz; Susan K Eszterhas; Petra A Sergent; David A Armstrong; Alix Ashare; Thomas Broughton; Li Wang; Dov Pechenick; Christopher M Burns; Randolph J Noelle; Matthew P Vincenti; Roy A Fava
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

9.  A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.

Authors:  Gaurav Mehta; Robert I Scheinman; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.

Authors:  Christoph Kessel; Kutty S Nandakumar; Francis B Peters; Varun Gauba; Peter G Schultz; Rikard Holmdahl
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.